Characteristics of non-AIDS-defining malignancies in the HAART era: A clinico-epidemiological study

Journal of the International AIDS Society

Volumn 14, Issue 1, 2011, Pages

  Dauby, Nicolas ^a   De Wit, Stéphane ^a   Delforge, Marc ^a   Necsoi, Valentina Coca ^a   Clumeck, Nathan ^a  

^a SAINT PIERRE UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ANTIRETROVIRUS AGENT; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGE; ANEMIA; ANUS CANCER; ARTICLE; BELGIUM; BLADDER CANCER; BREAST CANCER; CANCER INCIDENCE; CARDIOTOXICITY; CAUSE OF DEATH; CD4 LYMPHOCYTE COUNT; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE DURATION; FEBRILE NEUTROPENIA; FEMALE; HEAD AND NECK CANCER; HEPATITIS C; HERPES ZOSTER; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HODGKIN DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPLAN MEIER METHOD; KIDNEY FAILURE; LIVER CANCER; LOGISTIC REGRESSION ANALYSIS; LUNG ASPERGILLOSIS; LUNG CANCER; LUNG TUBERCULOSIS; MALE; MIXED INFECTION; MORTALITY; MYCOBACTERIOSIS; NEOPLASM; NEUTROPENIA; NON AIDS DEFINING MALIGNANCY; OBSERVATIONAL STUDY; OPPORTUNISTIC INFECTION; PANCYTOPENIA; PNEUMONIA; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; RISK FACTOR; SEX DIFFERENCE; STANDARDIZED INCIDENCE RATIO; SURVIVAL RATE; URBAN AREA; MIDDLE AGED; RETROSPECTIVE STUDY;

ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BELGIUM; COHORT STUDIES; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 79953115053     PISSN: None     EISSN: 17582652     Source Type: Journal    
DOI: 10.1186/1758-2652-14-16     Document Type: Article

References (40)

1. AIDS-related malignancies: state of the art and therapeutic challenges. JP Spano D Costagliola C Katlama N Mounier E Oksenhendler D Khayat, J Clin Oncol 2008 26 4834 4842 10.1200/JCO.2008.16.8252 18591544
2. Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDS. C Lewden D Salmon P Morlat S Bevilacqua E Jougla F Bonnet L Heripret D Costagliola T May G Chene, Int J Epidemiol 2005 34 121 130 10.1093/ije/dyh307 15561752 (Pubitemid 40347381)
3. Causes of death among persons with AIDS in the era of highly active antiretroviral therapy: New York City. JE Sackoff DB Hanna MR Pfeiffer LV Torian, Ann Intern Med 2006 145 397 406 16983127 (Pubitemid 46768570)
4. Cancer risk in HIV-infected persons: influence of CD4(+) count. GM Clifford S Franceschi, Future Oncol 2009 5 669 678 10.2217/fon.09.28 19519206
5. The impact of highly active antiretroviral therapy on non-AIDS-defining cancers among adults with AIDS. NA Hessol S Pipkin S Schwarcz RD Cress P Bacchetti S Scheer, American Journal of Epidemiology 2007 165 1143 1153 10.1093/aje/kwm017 17344204 (Pubitemid 47233717)
6. Pattern of cancer risk in persons with AIDS in Italy in the HAART era. L Dal Maso J Polesel D Serraino M Lise P Piselli F Falcini A Russo T Intrieri M Vercelli P Zambon G Tagliabue R Zanetti M Federico RM Limina L Mangone V De Lisi F Stracci S Ferretti S Piffer M Budroni A Donato A Giacomin F Bellu M Fusco A Madeddu S Vitarelli R Tessandori R Tumino B Suligoi S Franceschi, Br J Cancer 2009 100 840 847 10.1038/sj.bjc.6604923 19223894
7. Trends in cancer risk among people with AIDS in the United States 1980-2002. EA Engels RM Pfeiffer JJ Goedert P Virgo TS McNeel SM Scoppa RJ Biggar, AIDS 2006 20 1645 1654 10.1097/01.aids.0000238411.75324.59 16868446 (Pubitemid 44162407)
8. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. AE Grulich MT van Leeuwen MO Falster CM Vajdic, Lancet 2007 370 59 67 10.1016/S0140-6736(07)61050- 2 17617273 (Pubitemid 47017468)
9. Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study. M Guiguet F Boue J Cadranel JM Lang E Rosenthal D Costagliola, Lancet Oncol 2009 10 12 1152 1159 10.1016/S1470-2045(09)70282-7 19818686
10. Structure de la Population. Ministère de la Région de Bruxelles-Capitale - Institut Bruxellois de Statistiques et d'Analyse IBSA - Cellule Statistiques, Indicateurs Statistiques de la Région de Bruxelles-Capitale IRIS Editions 2009
11. Q Schoonvaere, Belgique - RD Congo: 50 années de migration. Etude de la migration congolaise et de son impact sur la présence congolaise en Belgique: analyse des principales données démographiques Bruxelles/Louvain-la-neuve: UCL/CECLR 2010
12. Highly active antiretroviral therapy and the incidence of non-AIDS-defining cancers in people with HIV infection. T Powles D Robinson J Stebbing J Shamash M Nelson B Gazzard S Mandelia H Moller M Bower, J Clin Oncol 2009 27 884 890 10.1200/JCO.2008.19.6626 19114688
13. Incidence and outcomes of malignancy in the HAART era in an urban cohort of HIV-infected individuals. JL Long EA Engels RD Moore KA Gebo, AIDS 2008 22 489 496 10.1097/QAD.0b013e3282f47082 18301061 (Pubitemid 351317290)
14. Cancer risk in people infected with human immunodeficiency virus in the United States. EA Engels RJ Biggar HI Hall H Cross A Crutchfield JL Finch R Grigg T Hylton KS Pawlish TS McNeel JJ Goedert, Int J Cancer 2008 123 187 194 10.1002/ijc.23487 18435450 (Pubitemid 351705208)
15. Smoke and mirrors: HIV-related lung cancer. A Bazoes M Bower T Powles, Curr Opin Oncol 2008 20 529 533 10.1097/CCO.0b013e32830a4c99 19106655
16. Belgian Cancer Registry, Cancer incidences in Belgium 2004-2005 Brussels 2008
17. Lung cancer in HIV infected patients: facts, questions and challenges. J Cadranel D Garfield A Lavole M Wislez B Milleron C Mayaud, Thorax 2006 61 1000 1008 10.1136/thx.2005.052373 17071836 (Pubitemid 44787172)
18. Risk of breast, ovary, and uterine corpus cancers among 85,268 women with AIDS. JJ Goedert C Schairer TS McNeel NA Hessol CS Rabkin EA Engels, Br J Cancer 2006 95 642 648 10.1038/sj.bjc.6603282 16868538 (Pubitemid 44325906)
19. Breast cancer before and during the AIDS epidemic in women and men: a study of Tanzanian Cancer Registry Data 1968 to 1996. H Amir E Kaaya G Kwesigabo J Kiitinya, Journal of the National Medical Association 2000 92 301 10918766
20. Incidence of non-AIDS-defining cancers before and during the highly active antiretroviral therapy era in a cohort of human immunodeficiency virus-infected patients. M Herida M Mary-Krause R Kaphan J Cadranel I Poizot-Martin C Rabaud N Plaisance H Tissot-Dupont F Boue JM Lang D Costagliola, J Clin Oncol 2003 21 3447 3453 10.1200/JCO.2003.01.096 12972519 (Pubitemid 46594077)
21. Breast cancer among HIV-infected patients: The experience of the European Institute of Oncology. M Intra O Gentilini F Brenelli E Chagas U Veronesi M Sandri, Journal of Surgical Oncology 2005 91 141 142 10.1002/jso.20315 16028288 (Pubitemid 41077057)
22. Use of mammographic screening by HIV-infected women in the Women's Interagency HIV Study (WIHS). S Preston-Martin LM Kirstein JM Pogoda B Rimer S Melnick L Masri-Lavine S Silver N Hessol AL French J Feldman HS Sacks M Deely AM Levine, Prev Med 2002 34 386 392 10.1006/pmed.2001.1003 11902857 (Pubitemid 34969599)
23. HIV Tropism and Decreased Risk of Breast Cancer. NA Hessol LA Napolitano D Smith Y Lie A Levine M Young M Cohen H Minkoff K Anastos G D'Souza RM Greenblatt JJ Goedert, PLoS ONE 2010 5 14349 10.1371/journal.pone.0014349 21179547
24. Functions of CXCL12 and CXCR4 in breast cancer. K Luker G Luker, Cancer Letters 2006 238 30 41 10.1016/j.canlet.2005.06.021 16046252 (Pubitemid 44183757)
25. Human Immunodeficiency Virus-Induced Apoptosis of Human Breast Cancer Cells Via CXCR4 is Mediated by the Viral Envelope Protein But Does Not Require CD4. S Misumi M Endo A Inatsu K Hashimoto N Takamune S Shoji, Current HIV Research 2008 6 34 42 10.2174/157016208783571991 18288973 (Pubitemid 351461019)
26. HIV-associated bladder cancer: a case series evaluating difficulties in diagnosis and management. EM Gaughan BJ Dezube M Bower DM Aboulafia G Bohac TP Cooley L Pantanowitz, BMC Urol 2009 9 10 10.1186/1471-2490-9-10 19719844
27. HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies. A Monforte D Abrams C Pradier R Weber P Reiss F Bonnet O Kirk M Law S De Wit N Friis-Moller AN Phillips CA Sabin JD Lundgren, AIDS 2008 22 2143 2153 10.1097/QAD.0b013e3283112b77 18832878
28. Trends in the incidence of cancers among HIV-infected persons and the impact of antiretroviral therapy: a 20-year cohort study. N Crum-Cianflone KH Hullsiek V Marconi A Weintrob A Ganesan RV Barthel S Fraser BK Agan S Wegner, AIDS 2009 23 41 50 10.1097/QAD.0b013e328317cc2d 19050385
29. Relationship between current level of immunodeficiency and non-acquired immunodeficiency syndrome-defining malignancies. J Reekie C Kosa F Engsig AdA Monforte A Wiercinska-Drapalo P Domingo F Antunes N Clumeck O Kirk JD Lundgren A Mocroft, Cancer 2010 116 5306 5315 10.1002/cncr.25311 20661911
30. Role of uncontrolled HIV RNA level and immunodeficiency in the occurrence of malignancy in HIV-infected patients during the combination antiretroviral therapy era: Agence Nationale de Recherche sur le Sida (ANRS) CO3 Aquitaine Cohort. M Bruyand R Thiebaut S Lawson-Ayayi P Joly AJ Sasco P Mercie JL Pellegrin D Neau F Dabis P Morlat G Chene F Bonnet, Clin Infect Dis 2009 49 1109 1116 10.1086/605594 19705973
31. CD4+ T cell responses in the immune control against latent infection by Epstein-Barr virus. C Paludan C Munz, Curr Mol Med 2003 3 341 347 10.2174/1566524033479771 12776989 (Pubitemid 36621791)
32. The Tumor/Immune Interface: Clinical Evidence of Cancer Immunosurveillance, Immunoediting and Immunosubversion. M Block S Markovic, American Journal of Immunology 2009 5 29 49 10.3844/ajisp.2009.29.49
33. Oncogenic properties of HIV-Tat in colorectal cancer cells. D Huynh E Vincan T Mantamadiotis D Purcell CK Chan R Ramsay, Current HIV research 2007 5 403 409 10.2174/157016207781023974 17627503 (Pubitemid 47040481)
34. HIV-1 Tat and AIDS-associated cancer: targeting the cellular anti-cancer barrier? G Nunnari JA Smith R Daniel, J Exp Clin Cancer Res 2008 27 3 10.1186/1756-9966-27-3 18577246
35. Uncontrolled viral replication as a risk factor for non-AIDS severe clinical events in HIV-infected patients on long-term antiretroviral therapy: APROCO/COPILOTE (ANRS CO8) cohort study. T Ferry F Raffi F Collin-Filleul M Dupon P Dellamonica A Waldner C Strady G Chene C Leport VL Moing, J Acquir Immune Defic Syndr 2009 51 407 415 10.1097/QAI.0b013e3181acb65f 19474755
36. Changes in cancer mortality among HIV-infected patients: the Mortalite 2005 Survey. F Bonnet C Burty C Lewden D Costagliola T May V Bouteloup E Rosenthal E Jougla P Cacoub D Salmon G Chene P Morlat, Clin Infect Dis 2009 48 633 639 10.1086/596766 19202627
37. Causes of death in HIV-infected women: persistent role of AIDS. The 'Mortalite 2000 & 2005' Surveys (ANRS EN19). M Hessamfar-Bonarek P Morlat D Salmon P Cacoub T May F Bonnet E Rosenthal D Costagliola C Lewden G Chene, Int J Epidemiol 2009 39 1 135 146 10.1093/ije/dyp300 19805489
38. African women with HIV in Brussels: Characteristics of a group with special needs [Abstract PE19.9/2]. E O'Doherty N Clumeck, 10th European AIDS Conference/EACS; November 17-20; Dublin, Ireland 2005
39. Interactions between antiretrovirals and antineoplastic drug therapy. T Antoniou AL Tseng, Clin Pharmacokinet 2005 44 111 145 10.2165/00003088- 200544020-00001 15656694 (Pubitemid 40188937)
40. Screening HIV-infected patients for non-AIDS-defining malignancies. AA Phillips JE Justman, Curr HIV/AIDS Rep 2009 6 83 92 10.1007/s11904-009-0013-0 19358779